{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:53:43Z","timestamp":1764842023074},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T00:00:00Z","timestamp":1518048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"South African National Research Foundation"},{"name":"South African Medical Research Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10067-018-4013-6","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T06:14:12Z","timestamp":1518070452000},"page":"1481-1491","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Disease severity impacts the relationship of apelin with arterial function in patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"37","author":[{"given":"Sul\u00e9","family":"Gunter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanel","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin R.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela J.","family":"Woodiwiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aletta M. E.","family":"Millen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick H.","family":"Dessein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,8]]},"reference":[{"key":"4013_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0167-0115(01)00236-1","volume":"99","author":"K Tatemoto","year":"2001","unstructured":"Tatemoto K, Takayama K, Zou MX, Kumaki I, Zhang W et al (2001) The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 99:87\u201392","journal-title":"Regul Pept"},{"key":"4013_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s10741-015-9475-x","volume":"20","author":"A Folino","year":"2015","unstructured":"Folino A, Montarolo PG, Samaja M, Rastaldo R (2015) Effects of apelin on the cardiovascular system. Heart Fail Rev 20:505\u2013518","journal-title":"Heart Fail Rev"},{"key":"4013_CR3","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1210\/en.2004-1427","volume":"146","author":"J Boucher","year":"2005","unstructured":"Boucher J, Masri B, Daviaud D, Gesta S, Guign\u00e9 C, Mazzucotelli A et al (2005) Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146:1764\u20131771","journal-title":"Endocrinology"},{"key":"4013_CR4","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jacc.2008.06.013","volume":"52","author":"AG Japp","year":"2008","unstructured":"Japp AG, Cruden NL, Amer DA, Li VK, Goudie EB, Johnston NR et al (2008) Vascular effects of apelin in vivo in man. J Am Coll Cardiol 52:908\u2013913","journal-title":"J Am Coll Cardiol"},{"key":"4013_CR5","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1139\/cjpp-2013-0046","volume":"91","author":"X Han","year":"2013","unstructured":"Han X, Zhang DL, Yin DX, Zang QD, Lui WH (2013) Apelin-13 deteriorates hypertension in rats after damage of the vascular endothelium by ADMA. Can J Physiol Pharmacol 91:708\u2013714","journal-title":"Can J Physiol Pharmacol"},{"key":"4013_CR6","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/sj.bjp.0703939","volume":"132","author":"SD Katugampola","year":"2001","unstructured":"Katugampola SD, Maguire JJ, Matthewson SR, Davenport AP (2001) [(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man. Br J Pharmacol 132:1255\u20131260","journal-title":"Br J Pharmacol"},{"key":"4013_CR7","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1161\/01.ATV.0000218841.39828.91","volume":"26","author":"T Hashimoto","year":"2006","unstructured":"Hashimoto T, Kihara M, Ishida J, Imai N, Yoshida SI, Toya Y et al (2006) Apelin stimulates myosin light chain phosphorylation in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 26:1267\u20131272","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4013_CR8","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1016\/j.peptides.2011.10.001","volume":"32","author":"LY Wang","year":"2011","unstructured":"Wang LY, Zhang DL, Zheng JF, Zhang Y, Zhang QD, Liu WH (2011) Apelin-13 passes through the ADMA-damaged endothelial barrier and acts on vascular smooth muscle cells. Peptides 32:2436\u20132443","journal-title":"Peptides"},{"key":"4013_CR9","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3892\/mmr.2013.1378","volume":"7","author":"K Nagano","year":"2013","unstructured":"Nagano K, Ishida J, Unni M, Matsura T, Fukamizu A (2013) Apelin elevates blood pressure in ICR mice with L-NAME induced endothelial dysfunction. Mol Med Rep 7:1371\u20131375","journal-title":"Mol Med Rep"},{"key":"4013_CR10","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.bbrc.2007.04.017","volume":"357","author":"K Farkasfalvi","year":"2007","unstructured":"Farkasfalvi K, Stagg MA, Coppen SR, Siedlecka U, Lee J, Soppa GK (2007) Direct effects of apelin on cardiomyocyte contractility and electrophysiology. Biochem Biophys Res Commun 357:889\u2013895","journal-title":"Biochem Biophys Res Commun"},{"key":"4013_CR11","doi-asserted-by":"publisher","first-page":"e93473","DOI":"10.1371\/journal.pone.0093473","volume":"9","author":"\u00c1 Perj\u00e9s","year":"2014","unstructured":"Perj\u00e9s \u00c1, Skoumal R, Tenhunen O, K\u00f3nyi A, Simon M, Horv\u00e1th IG (2014) Apelin increases cardiac contractility via protein kinase C\u03b5-and extracellular signal-regulated kinase-dependent mechanisms. PloS One 9:e93473","journal-title":"PloS One"},{"key":"4013_CR12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.bbrc.2015.09.045","volume":"466","author":"F Yao","year":"2015","unstructured":"Yao F, Lv YC, Zhang M, Xie W, Tan YL, Gong D et al (2015) Apelin-13 impedes foam cell formation by activating Class III PI3K\/Beclin-1-mediated autophagic pathway. Biochem Biophys Res Commun 466:637\u2013643","journal-title":"Biochem Biophys Res Commun"},{"key":"4013_CR13","first-page":"3343","volume":"118","author":"HJ Chun","year":"2008","unstructured":"Chun HJ, Ali ZA, Kojima Y, Kundu RK, Sheikh AY, Agrawal R et al (2008) Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. J Clin Invest 118:3343\u20133354","journal-title":"J Clin Invest"},{"key":"4013_CR14","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1182\/blood-2014-05-578781","volume":"127","author":"F Adam","year":"2016","unstructured":"Adam F, Khatib A-M, Lopez JJ, Vatier C, Turpin S, Muscat A et al (2016) Apelin: an antithrombotic factor that inhibits platelet function. Blood 127:908\u2013920","journal-title":"Blood"},{"key":"4013_CR15","doi-asserted-by":"publisher","first-page":"e93545","DOI":"10.1371\/journal.pone.0093545","volume":"9","author":"S Fujie","year":"2014","unstructured":"Fujie S, Sato K, Miyamoto-Mikami E, Hasegawa N, Fujita S, Sanada K et al (2014) Reduction of arterial stiffness by exercise training is associated with increasing plasma apelin levels in middle-aged and older adults. PLoS One 9:e93545","journal-title":"PLoS One"},{"key":"4013_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.mce.2015.04.006","volume":"411","author":"Y-C Liao","year":"2015","unstructured":"Liao Y-C, Wang Y-S, Hsi E, Chang M-H, You Y-Z, Juo S-HH (2015) MicroRNA-765 influences arterial stiffness through modulating apelin expression. Mol Cell Endocrinol 411:11\u201319","journal-title":"Mol Cell Endocrinol"},{"key":"4013_CR17","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.116.023218","volume":"135","author":"P Yang","year":"2017","unstructured":"Yang P, Read C, Kuc RE, Buonincontri G, Southwood M, Torella R et al (2017) Elabela\/Toddler is an endogenous agonist of the apelin APJ receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension. Circulation 135:1160\u20131173","journal-title":"Circulation"},{"key":"4013_CR18","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1161\/HYP.0000000000000033","volume":"66","author":"RR Townsend","year":"2015","unstructured":"Townsend RR, Schiffrin EL, Avalo AP, Chirinos JA, Cockroft JR, Heffernan KS et al (2015) Recommendations for improving and standardizing vascular research on arterial stiffness. A scientific statement from the American Heart Association. Hypertension 66:698\u2013722","journal-title":"Hypertension"},{"key":"4013_CR19","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S0735-1097(01)01108-1","volume":"37","author":"AM Dart","year":"2001","unstructured":"Dart AM, Kingwell BA (2001) Pulse pressure\u2014a review of mechanisms and clinical relevance. J Am Coll Cardiol 37:975\u2013984","journal-title":"J Am Coll Cardiol"},{"key":"4013_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","volume":"76","author":"R Agca","year":"2017","unstructured":"Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJL et al (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis 76:17\u201328","journal-title":"Ann Rheum Dis"},{"key":"4013_CR21","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.berh.2016.10.006","volume":"30","author":"S Castaneda","year":"2016","unstructured":"Castaneda S, Nurmohamed MT, Gonzalez-Gay MA (2016) Cardiovascular disease in inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol 30:851\u2013869","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4013_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3109\/07853890.2015.1068950","volume":"47","author":"P Ambrosino","year":"2015","unstructured":"Ambrosino P, Tasso M, Lupoli R, Di Minno A, Baldassarre D, Tremoli E et al (2015) Non-invasive assessment of arterial stiffness in patients with rheumatoid arthritis: a systematic review and meta-analysis of literature studies. Ann Med 47:457\u2013467","journal-title":"Ann Med"},{"key":"4013_CR23","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/ard.62.5.414","volume":"62","author":"R Klocke","year":"2003","unstructured":"Klocke R, Cockroft JR, Taylor GJ, Hall IR, Blake DR (2003) Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis 62:414\u2013418","journal-title":"Ann Rheum Dis"},{"key":"4013_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semarthrit.2012.02.002","volume":"42","author":"R Dulai","year":"2012","unstructured":"Dulai R, Perry M, Twycross-Lewis R, Morrissey D, Atzeni F, Greenwald S (2012) The effect of tumor necrosis factor-\u03b1 antagonists on arterial stiffness in rheumatoid arthritis: a literature review. Semin Arthritis Rheum 42:1\u20138","journal-title":"Semin Arthritis Rheum"},{"key":"4013_CR25","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3899\/jrheum.170029","volume":"44","author":"S Gunter","year":"2016","unstructured":"Gunter S, Robinson C, Norton GR, Woodiwiss AJ, Tsang L, Dessein PH et al (2016) Cardiovascular risk factors and disease characteristics are consistently associated with arterial function in rheumatoid arthritis. J Rheumatol 44:1125\u20131133","journal-title":"J Rheumatol"},{"key":"4013_CR26","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.3899\/jrheum.160053","volume":"43","author":"E Ikdahl","year":"2016","unstructured":"Ikdahl E, Rollefstad S, Wibetoe G, Olsen IC, Berg IJ, Hisdal J et al (2016) Predictive value of arterial stiffness and subclinical carotid atherosclerosis for cardiovascular disease in patients with rheumatoid arthritis. J Rheumatol 43:1622\u20131630","journal-title":"J Rheumatol"},{"key":"4013_CR27","doi-asserted-by":"publisher","unstructured":"Di Franco M, Spinelli FR, Metere A, Gerardi MC, Conti V, Boccalini F et al (2012) Serum levels of asymmetric dimethylarginine and apelin as potential markers of vascular endothelial dysfunction in early rheumatoid arthritis. Mediat Inflamm. \n                    https:\/\/doi.org\/10.1155\/2012\/347268","DOI":"10.1155\/2012\/347268"},{"key":"4013_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.atherosclerosis.2016.11.024","volume":"256","author":"S Gunter","year":"2017","unstructured":"Gunter S, Solomon A, Tsang L, Woodiwiss AJ, Robinson C, Millen AM et al (2017) Apelin concentrations are associated with altered atherosclerotic plaque stability mediator levels and atherosclerosis in rheumatoid arthritis. Atherosclerosis 256:75\u201381","journal-title":"Atherosclerosis"},{"key":"4013_CR29","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1161\/01.ATV.0000033516.73864.4E","volume":"22","author":"R Bergholm","year":"2002","unstructured":"Bergholm R, Leirisalo-Repo M, Vehkavaara S, Makimattila S, Taskinen MR, Yki-Jarvinen H (2002) Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis. Arterioscler Thromb Vasc Biol 22:1637\u20131641","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4013_CR30","doi-asserted-by":"publisher","unstructured":"Dessein PH, Solomon A, Woodiwiss AJ, Norton GR, Tsang L, Gonzalez-Gay MA (2013) Marked independent relationship between circulating interleukin-6 concentrations and endothelial activation in rheumatoid arthritis. Mediat Inflamm. \n                    https:\/\/doi.org\/10.1155\/2013\/510243","DOI":"10.1155\/2013\/510243"},{"key":"4013_CR31","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1038\/s41598-017-05759-2","volume":"7","author":"F Ursini","year":"2017","unstructured":"Ursini F, Leporini C, Bene F, D\u2019Angelo S, Mauro D, Russo E et al (2017) Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis. Sci Rep 7:5346","journal-title":"Sci Rep"},{"key":"4013_CR32","first-page":"161","volume":"24","author":"PH Dessein","year":"2006","unstructured":"Dessein PH, Joffe BI (2006) Suppression of circulating interleukin-6 concentrations is associated with decreased endothelial activation in rheumatoid arthritis. Clin Exp Rheum 24:161\u2013167","journal-title":"Clin Exp Rheum"},{"key":"4013_CR33","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DJ, Bingham CO 3rd et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580\u20131588","journal-title":"Ann Rheum Dis"},{"key":"4013_CR34","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1161\/HYPERTENSIONAHA.115.05159","volume":"65","author":"E Libhaber","year":"2015","unstructured":"Libhaber E, Woodiwiss AJ, Raymond A, Gomes M, Maseko MJ, Sareli P et al (2015) Independent associations of circulating galectin-3 concentrations with aortic pulse wave velocity and wave reflection in a community sample. Hypertension 65:1356\u20131364","journal-title":"Hypertension"},{"key":"4013_CR35","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/01.CIR.58.6.1072","volume":"58","author":"DJ Sahn","year":"1978","unstructured":"Sahn DJ, De Maria A, Kisslo J, Weyman A (1978) Recommendations regarding quantitation in M- mode echocardiography: results of a survey of echocardiographic measurement. Circulation 58:1072\u20131083","journal-title":"Circulation"},{"key":"4013_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0002-9149(76)90491-4","volume":"37","author":"LE Teichholz","year":"1976","unstructured":"Teichholz LE, Kreulen T, Herman MV, Gorlin R (1976) Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 37:7\u201311","journal-title":"Am J Cardiol"},{"key":"4013_CR37","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","volume":"57","author":"RB Devereux","year":"1986","unstructured":"Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al (1986) Echocardiograph assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450\u2013458","journal-title":"Am J Cardiol"},{"key":"4013_CR38","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/0735-1097(92)90617-V","volume":"19","author":"A Ganau","year":"1992","unstructured":"Ganau A, Devereux RB, Roman MJ, De Simone G, Pickering TG, Saba PS et al (1992) Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 19:1550\u20131558","journal-title":"J Am Coll Cardiol"},{"key":"4013_CR39","first-page":"1011","volume":"14","author":"P Palatini","year":"1996","unstructured":"Palatini P, Visentin P, Nicolosi G, Mione V, Stritoni P, Michieletto M et al (1996) Endocardial versus midway measurement of left ventricular function in mild hypertension: an insight to the harvest study. J Hypertens 14:1011\u20131017","journal-title":"J Hypertens"},{"key":"4013_CR40","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/HYPERTENSIONAHA.109.134619","volume":"54","author":"JJ Maguire","year":"2009","unstructured":"Maguire JJ, Kleinz MJ, Pitkin SL, Davenport AP (2009) [Pyr1]Apelin-13 identified as the predominant apelin isoform in the human heart. Vasoactive mechanisms and inotropic action in disease. Hypertension 54:598\u2013604","journal-title":"Hypertension"},{"key":"4013_CR41","doi-asserted-by":"publisher","first-page":"316","DOI":"10.18203\/2319-2003.ijbcp20170322","volume":"6","author":"V Wilson","year":"2017","unstructured":"Wilson V, Prabhakar P, Seth S, Maulik SK (2017) Current evidence-based therapy does not restore plasma apelin level in phenotypically diverse chronic heart failure patients. Int J Basic Clin Pharmacol 6:316\u2013322","journal-title":"Int J Basic Clin Pharmacol"},{"key":"4013_CR42","doi-asserted-by":"publisher","first-page":"e0146744","DOI":"10.1371\/journal.pone.0146744","volume":"11","author":"P Totoson","year":"2016","unstructured":"Totoson P, Maguin-Gat\u00e9 K, Nappey M, Wendling D, Demougeot C (2016) Endothelial dysfunction in rheumatoid arthritis: mechanistic insights and correlation with circulating markers of systemic inflammation. PLoS One 11:e0146744","journal-title":"PLoS One"},{"key":"4013_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13075-017-1232-1","volume":"19","author":"T Dimitroulos","year":"2017","unstructured":"Dimitroulos T, Hodson J, Sandoo A, Smith J, Kitas GD (2017) Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation. Arthritis Res Ther 19:32","journal-title":"Arthritis Res Ther"},{"key":"4013_CR44","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1161\/01.CIR.103.9.1245","volume":"103","author":"SS Franklin","year":"2001","unstructured":"Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB et al (2001) Does the relation of blood pressure to coronary heart disease risk change with aging? Circulation 103:1245\u20131249","journal-title":"Circulation"},{"key":"4013_CR45","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/S0735-1097(03)00295-X","volume":"41","author":"R Ceravolo","year":"2003","unstructured":"Ceravolo R, Maio R, Pujia A, Sciacqua A, Ventura G, Costa MC et al (2003) Pulse pressure and endothelial dysfunction in never-treated hypertensive patients. J Am Coll Cardiol 41:1753\u20131758","journal-title":"J Am Coll Cardiol"},{"issue":"12 Suppl 1","key":"4013_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1524-6175.2006.06032.x","volume":"8","author":"M Hermann","year":"2006","unstructured":"Hermann M, Flammer A, L\u00fcscher TF (2006) Nitric oxide in hypertension. J Clin Hypertens 8(12 Suppl 1):17\u201329","journal-title":"J Clin Hypertens"},{"key":"4013_CR47","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1136\/annrheumdis-2013-203587","volume":"72","author":"PH Dessein","year":"2013","unstructured":"Dessein PH, Norton GR, Woodiwiss AJ, Solomon A (2013) Independent relationship between circulating resistin concentrations and endothelial activation in rheumatoid arthritis. Ann Rheum Dis 72:1586\u20131588","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4013-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4013-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4013-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T00:42:28Z","timestamp":1549586548000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4013-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,8]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["4013"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4013-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,8]]},"assertion":[{"value":"27 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study was approved by the University of Witwatersrand Human (Medical) Research Ethics Committee (approval number: M06-07-33; protocol number: M120562). All patients gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}